Congratulations to A/Prof Edwina Wright, Department of Infectious Diseases who successfully chaired a submission to Pharmaceutical Benefits Advisory Committee (PBAC) by ASHM, NAPWA and AFAO, following which, the PBAC lifted CD4+ cell
restrictions on prescribing antiretroviral therapy for HIV+ people. This means
that all HIV+ people irrespective of how high their CD4+ cells are, or whether
or not they have symptoms, can access antiretroviral therapy. http://ow.ly/t5TNw
(Formerly known as Central Clinical School)
29 Jan 2014
A/Prof Edwina Wright's advocacy for Australian HIV+ patients helps create access to therapy
Congratulations to A/Prof Edwina Wright, Department of Infectious Diseases who successfully chaired a submission to Pharmaceutical Benefits Advisory Committee (PBAC) by ASHM, NAPWA and AFAO, following which, the PBAC lifted CD4+ cell
restrictions on prescribing antiretroviral therapy for HIV+ people. This means
that all HIV+ people irrespective of how high their CD4+ cells are, or whether
or not they have symptoms, can access antiretroviral therapy. http://ow.ly/t5TNw
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Thankyou for your comment. We moderate all messages and may take a little time to review your comment. Please email inquiries to ccs.comms@monash.edu.